Medifast, Inc.MEDNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-68.7%
5Y CAGR-52.0%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-68.7%/yr
vs -4.4%/yr prior
5Y CAGR
-52.0%/yr
Recent deceleration
Acceleration
-64.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 0.38% | -85.4% |
| 2024 | 2.59% | -80.1% |
| 2023 | 13.01% | +6.3% |
| 2022 | 12.24% | -16.2% |
| 2021 | 14.62% | -1.3% |
| 2020 | 14.81% | +10.5% |
| 2019 | 13.40% | -8.6% |
| 2018 | 14.67% | +0.9% |
| 2017 | 14.54% | +23.7% |
| 2016 | 11.75% | - |